23 August 2021
Innovative healthtech companies across Leeds City Region now have the opportunity to apply for a pioneering US Accelerator programme, specifically developed to help UK companies accelerate their business stateside.
The Association for British HealthTech Industries (ABHI) – the UK’s leading industry association for health technology and a key partner in the Leeds City Region’s Healthtech Catalyst – has announced that applications for the ABHI US Accelerator 2022 cohort are open.
Now in its fourth year, the ABHI US Accelerator, conducted in partnership with the Dell Medical School in Austin, Texas, is aimed at UK medical device, diagnostic and digital health companies looking to access the US healthcare landscape.
The 12-month programme of support provides companies with the opportunity to define and strengthen their US strategy, de-risk market entry and grow their US business by utilising ABHI’s advice, expertise and connections within the country.
The programme also facilitates introductions to hospital, clinical, and supply chain leaders, enabling companies to liaise directly with decision-makers to discuss their products and services.
In addition, and with the support of ABHI’s broad network of partners within US health systems, participating companies enjoy exclusive access to ABHI’s full year-round programme of trade missions and virtual activity across the US.
The 2022 programme will run from January 2022 – December 2022, with participants able to make full use of ABHI’s dedicated workspace and office at the Dell Medical School, with access to their facilities and support from senior faculty.
Paul Benton, Managing Director, International, said: “The ABHI US Accelerator is a great way to help drive your business within the world’s largest HealthTech market, especially following what has been a hard-hit year for global trade.
“Through the ABHI US Accelerator, companies have exclusive access to our extensive network and the advice and expertise it offers, including unrivalled access to senior physicians, c-suite level health system executives, and a whole host of US healthcare contacts.
“Feedback from previous cohorts has been incredibly positive, with many delegates expressing how transformational the experience has been for them and their businesses. We look forward to this year’s field of submissions and encourage any HealthTech companies looking to upscale their US business to apply.”
Since its establishment in 2017, the ABHI US Accelerator has led to over 25 international research collaborations and new business generated for UK industry.
The programme has been expanded over the years, and is now supporting 30 companies drive their operations in the US. Centred in Texas, and using the state as a springboard to other key states, the programme offers nationwide support, drawing on the relationships and connections built up across the US.
Dr Liz Mear, Managing Director, Leeds Academic Health Partnership, said: “This is a superb opportunity for healthtech businesses in our region, which is already a leading healthtech hub.
“It comes at a time when – as a region – we are making huge strides forward to support and strengthen our national and international healthtech offer.
“We will promote this opportunity through our Healthtech Catalyst which connects partners and players across the region to stimulate and accelerate growth in the sector.”
To apply, or for an informal discussion on the opportunity, contact firstname.lastname@example.org
ABHI is the UK’s leading industry association for health technology (HealthTech).
ABHI supports the HealthTech community to save and enhance lives. Members, including both multinationals and small and medium sized enterprises (SMEs), supply products from syringes and wound dressings to surgical robots and digitally enhanced technologies. We represent the industry to stakeholders, such as the government, NHS and regulators. HealthTech plays a key role in supporting delivery of healthcare and is a significant contributor to the UK’s economic growth. HealthTech is now the largest employer in the broader Life Sciences sector, employing 131,800 people in 4,060 companies, with a combined turnover of £25.6bn. The industry has enjoyed growth of around 5% in recent years. ABHI’s 320 members account for approximately 80% of the sector by value.
Back to news and events